Naftifine versus miconazole/hydrocortisone in inflammatory dermatophyte infections.
Nada
M
M
Department of Dermatology, Cairo University, Egypt.
Hanafi
S
S
al-Omari
H
H
Mokhtar
M
M
el-Shamy
S
S
Mühlbacher
J
J
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000499:Allylamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003881:Dermatomycoses / Q000188:drug therapy* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use*; D007249:Inflammation / Q000188:drug therapy; D008297:Male; D008825:Miconazole / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D014005:Tinea / Q000188:drug therapy / Q000503:physiopathology; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000935:Antifungal Agents; D000499:Allylamine; C029178:naftifine; D008825:Miconazole; D006854:Hydrocortisone